Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothrombin Complex Concentrate in Hemophilia B
CTR20180274Phase 3Completed
- Sponsor
- Shenzhen Weiguang Biological Products
- Start
- Mar 2018
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Shenzhen Weiguang Biological Products. Started Mar 2018; status: completed.
02
Drugs
balfaxar
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20180274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180274.